Novel CD19/CD22 Bicistronic Chimeric Antigen Receptors Outperform Single or Bivalent Cars in Eradicating CD19+ CD22+, CD19-, and CD22- Pre-B Leukemia

被引：0
|
作者：
Qin, Haiying
Nguyen, Sang M.
Ramakrishna, Sneha
Tarun, Samiksha
Yang, Lila
Verdini, Nicholas Peter
Haso, Waleed
Fry, Terry J.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
810
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Preclinical Development of Bivalent Chimeric Antigen Receptors Targeting Both CD19 and CD22
    Qin, Haiying
    Ramakrishna, Sneha
    Nguyen, Sang
    Fountaine, Thomas J.
    Ponduri, Anusha
    Stetler-Stevenson, Maryalice
    Yuan, Constance M.
    Haso, Waleed
    Shern, Jack F.
    Shah, Nirali N.
    Fry, Terry J.
    MOLECULAR THERAPY-ONCOLYTICS, 2018, 11 : 127 - 137
  • [2] Circulating CD22+/CD19-/CD24-progenitors and CD22+/CD19+/CD24-mature B cells: Diagnostic pitfalls for minimal residual disease detection in B-lymphoblastic leukemia
    Zhou, Ting
    Karrs, Jeremiah
    Ho, Truc
    Doverte, Alyssa
    Kochenderfer, James N.
    Shah, Nirali N.
    Yuan, Constance M.
    Wang, Hao-Wei
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2023, 104 (04) : 294 - 303
  • [3] Targeting B Cell Precursor Acute Lymphoblastic Leukemia (ALL) with Chimeric Antigen Receptors (CARs) Specific for CD19 or CD22
    Orentas, Rimas J.
    Haso, Waleed
    Lee, Daniel W.
    Fry, Terry J.
    Wayne, Alan S.
    Mackall, Crystal L.
    MOLECULAR THERAPY, 2013, 21 : S125 - S125
  • [4] Heterogeneity of surface CD19 and CD22 expression in B lymphoblastic leukemia
    Rosenthal, Jaclyn
    Naqvi, Ammar S.
    Luo, Minjie
    Wertheim, Gerald
    Paessler, Michele
    Thomas-Tikhonenko, Andrei
    Rheingold, Susan R.
    Pillai, Vinodh
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (11) : E352 - E355
  • [5] Preclinical Development of Bispecific Chimeric Antigen Receptor Targeting Both CD19 and CD22
    Qin, Haiying
    Haso, Waleed
    Sang Minh Nguyen
    Fry, Terry J.
    BLOOD, 2015, 126 (23)
  • [6] Human basophils express CD22 without expression of CD19
    Han, KJ
    Kim, Y
    Lee, J
    Lim, J
    Lee, KY
    Kang, CS
    Kim, WI
    Kim, BK
    Shim, SI
    Kim, SM
    CYTOMETRY, 1999, 37 (03): : 178 - 183
  • [7] A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukemia
    Wang, Yiyun
    Yang, Yingying
    Hong, Ruimin
    Zhao, Houli
    Wei, Guoqing
    Wu, Wenjun
    Xu, Huijun
    Cui, Jiazhen
    Zhang, Yanlei
    Chang, Alex H.
    Hu, Yongxian
    Huang, He
    BLOOD CANCER JOURNAL, 2020, 10 (10)
  • [8] A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukemia
    Yiyun Wang
    Yingying Yang
    Ruimin Hong
    Houli Zhao
    Guoqing Wei
    Wenjun Wu
    Huijun Xu
    Jiazhen Cui
    Yanlei Zhang
    Alex H. Chang
    Yongxian Hu
    He Huang
    Blood Cancer Journal, 10
  • [9] Correlation of CD19 and CD22 Expression Level with Response to Novel Immunotherapeutics in B-Lymphoblastic Leukemia
    Rosenthal, Jaclyn
    Naqvi, Ammar
    Wertheim, Gerald
    Paessler, Michele
    Rheingold, Susan
    Thomas-Tikhonenkho, Andrei
    Pillai, Vinodh
    MODERN PATHOLOGY, 2018, 31 : 548 - 548
  • [10] Correlation of CD19 and CD22 Expression Level with Response to Novel Immunotherapeutics in B-Lymphoblastic Leukemia
    Rosenthal, Jaclyn
    Naqvi, Ammar
    Wertheim, Gerald
    Paessler, Michele
    Rheingold, Susan
    Thomas-Tikhonenkho, Andrei
    Pillai, Vinodh
    LABORATORY INVESTIGATION, 2018, 98 : 548 - 548
12345